Aragen Life Sciences

Chemical Development Solutions of GVK BIO provides a convenient, single-site distribution of infrastructure, thereby delivering a seamless and innovative transition of solutions from lab to pilot plant and bulk manufacturing, with speed and quality.

We ensure quality in the process during th...

GVK BIO offers long term Contract Manufacturing Solutions in development, validations, DMF filing, manufacturing of New Chemical Entities (NCE), Active Pharmaceutical Ingredients (API) and Intermediates.

Capabilities:Environment friendly routes under GMP conditions
Robust and cost-effective p...

GVK BIO offers a range of Formulation R&D solutions that include pre-formulation studies, formulation development, analytical R&D, reformulation and stability studies. We can also support clinical supplies and manufacturing of exhibit batches in collaboration with our partners and offer standalone ...

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, in each of the different categories, from digital innovation to CEO of the year. 

With safety being our highest priority, we continue to be a reliable partner in accelerating research and development of our customers. Here’s a look at some of the precautionary measures taken against Covid19 across GVK BIO’s campuses.

Navigating the transition from late pre-clinical stages to commercial success in the biotech and pharmaceutical industries requires a delicate balance between speed and cost efficiency. This session will explore strategic approaches to streamline this critical phase, ensuring timely market entry while controlling cost. It will deep diver into the best practices for managing late-stage development, overcoming regulatory hurdles, and scaling up production. The speaker will share insights on optimizing resource allocation, leveraging innovative technologies, and fostering strategic partnerships to enhance both speed and cost-effectiveness. Attendees will gain actionable strategies to minimize time-to-market and maximize return on investment, ensuring successful commercial launches. Join us to learn how to effectively manage the complexities and sensitivities of advancing from pre-clinical trials to commercial deployment.